2009 Atherosclerosis Gordon Research Conference

2009年动脉粥样硬化戈登研究会议

• 批准号: 7669740
• 负责人: Martha K Cathcart
• 金额: $ 1.5万
• 依托单位: GORDON RESEARCH CONFERENCES
• 依托单位国家: 美国
• 财政年份: 2009
• 资助国家: 美国
• 起止时间: 2009-05-01 至 2010-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/7669740
• 关键词: Area; Arterial Fatty Streak; Atherosclerosis; Biology; Blood Vessels; Cardiovascular Diseases; Cause of Death; Cell Lineage; Chronic; Complex; Country; Development; Diabetes Mellitus; Diagnostic; Discipline; Disease; Etiology; Future; Genetic; Genomics; Heterogeneity; Inflammation; Inflammatory; Knowledge; Lesion; Lipids; Lipoproteins; Minority; New Hampshire; Participant; Public Health; Qualifying; Research; Resolution; Resources; Schools; Scientist; Stem cells; Systems Biology; Technology; Therapeutic; Ursidae Family; Vascular Diseases; Woman; abstracting; career; frontier; macrophage; meetings; posters; stem cell biology; symposium

DESCRIPTION (provided by applicant): The 19th Gordon Research Conference on Atherosclerosis will be held at Tilton School in Tilton, New Hampshire on June 21-26, 2009. This conference has been held every two years since 1973. The conference enjoys a worldwide reputation, and brings together highly qualified participants from all levels of career status and from a variety of backgrounds for "off-the-record," high quality intensive discussions of research at the frontiers of knowledge in atherosclerosis. This integrative conference has been particularly valuable in atherosclerosis research because of the multiple and distinct disciplines that bear on the origin and progression of this complex, multifaceted disease. The Atherosclerosis Gordon Conference will provide an overview of the most important recent developments in the pathobiology of atherosclerosis. The meeting will discuss all aspects of atherosclerotic lesion development, progression and resolution as well as current and future therapeutic approaches. Throughout, special emphasis will be placed on cutting edge technologies and resources that are relevant to the study of atherosclerosis. Nine sessions are planned and will cover the following topics: 1. Macrophage heterogeneity; 2. Systems biology of atherosclerosis; 3. Genomics and genetics of atherosclerosis; 4. Stem cells and lineage acquisition; 5. Lesion dynamics and calcific vasculopathy; 6. Lipids, lipoproteins and dysmetabolic conditions; 7. Lesion reversibility; 8. Chronicity of inflammation; 9. Future therapeutics and diagnostics. The conference will be a major vehicle for the integration of new knowledge in the field of atherosclerosis research. In order to stimulate an interdisciplinary dialogue, speakers will be invited who represent distinct but overlapping areas of research such as; stem cell biology, genomics, lipoproteins, diabetes and vascular biology. The conference will encourage the participation of women and minorities. Some of the invited speakers will be junior scientists and participation of junior scientists and trainees will also be encouraged through poster sessions. The conference will provide a comprehensive overview of current research on atherosclerosis with a focus on the latest and most exciting developments in the field and future therapeutic approaches. (End of Abstract)

描述(由申请人提供)： 第19届戈登动脉粥样硬化研究会议将于2009年6月21-26日在新罕布夏州蒂尔顿的蒂尔顿学校举行。自1973年以来，该会议每两年举行一次。这次会议享誉全球，聚集了来自不同职业地位和不同背景的高素质与会者，就动脉粥样硬化知识前沿的“非正式”、高质量的密集研究进行讨论。这次综合性会议在动脉粥样硬化研究中特别有价值，因为涉及到这种复杂、多方面疾病的起源和发展的多个和不同的学科。动脉粥样硬化戈登会议将提供动脉粥样硬化病理生物学中最重要的最新发展的概述。会议将讨论动脉粥样硬化病变发展、进展和解决的方方面面，以及当前和未来的治疗方法。在整个过程中，将特别强调与动脉粥样硬化研究相关的尖端技术和资源。计划举办9场会议，涵盖以下主题：1.巨噬细胞的异质性；2.动脉粥样硬化的系统生物学；3.动脉粥样硬化的基因组学和遗传学；4.干细胞和谱系的获取；5.病变动力学和钙化性血管病变；6.脂质、脂蛋白和代谢障碍；7.病变的可逆性；8.炎症的慢性；9.未来的治疗和诊断。这次会议将是整合动脉粥样硬化研究领域新知识的主要载体。为了促进跨学科对话，将邀请代表不同但重叠的研究领域的发言者，如干细胞生物学、基因组学、脂蛋白、糖尿病和血管生物学。会议将鼓励妇女和少数民族参加。一些被邀请的演讲者将是初级科学家，初级科学家和受训人员的参与也将通过海报会议得到鼓励。这次会议将全面概述目前对动脉粥样硬化的研究，重点是该领域最新和最令人兴奋的发展和未来的治疗方法。(摘要结束)